Tandem Diabetes Care, Inc.
TNDM
$21.01
$0.281.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 249.25M | 240.68M | 234.42M | 282.65M | 243.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 249.25M | 240.68M | 234.42M | 282.65M | 243.97M |
| Cost of Revenue | 114.96M | 114.82M | 116.02M | 125.19M | 119.32M |
| Gross Profit | 134.29M | 125.86M | 118.41M | 157.46M | 124.65M |
| SG&A Expenses | 108.44M | 109.60M | 104.97M | 105.84M | 99.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 272.12M | 272.54M | 268.92M | 283.23M | 270.06M |
| Operating Income | -22.86M | -31.86M | -34.49M | -582.00K | -26.09M |
| Income Before Tax | -25.14M | -57.72M | -122.09M | 16.00K | -22.61M |
| Income Tax Expenses | -3.98M | -5.32M | 8.47M | -739.00K | 637.00K |
| Earnings from Continuing Operations | -21.17M | -52.40M | -130.56M | 755.00K | -23.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.17M | -52.40M | -130.56M | 755.00K | -23.25M |
| EBIT | -22.86M | -31.86M | -34.49M | -582.00K | -26.09M |
| EBITDA | -18.37M | -27.49M | -30.18M | 3.66M | -21.88M |
| EPS Basic | -0.31 | -0.78 | -1.97 | 0.01 | -0.35 |
| Normalized Basic EPS | -0.23 | -0.35 | -0.34 | 0.02 | -0.22 |
| EPS Diluted | -0.31 | -0.78 | -1.97 | 0.01 | -0.35 |
| Normalized Diluted EPS | -0.23 | -0.35 | -0.34 | 0.02 | -0.22 |
| Average Basic Shares Outstanding | 67.65M | 67.05M | 66.40M | 65.94M | 65.54M |
| Average Diluted Shares Outstanding | 67.65M | 67.05M | 66.40M | 66.16M | 65.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |